Search results
Results from the WOW.Com Content Network
Oxycodone was first made available in the United States in 1939. In the 1970s, the FDA classified oxycodone as a Schedule II drug, indicating a high potential for non-medical use and addiction. After its 1995 approval by the FDA by Deputy Director Curtis Wright IV , [ 105 ] Purdue Pharma introduced OxyContin, a controlled release formulation of ...
This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources. The timeline of the opioid epidemic includes selected events related to the origins of Stamford, Connecticut-based Purdue Pharma, the Sackler family, the development and marketing of oxycodone, selected FDA activities related to the abuse ...
The continued prevalence of the opioid epidemic in the United States can be traced to many reasons. For one, there is a lack of appropriate treatments and treatment centers across the nation. [ 39 ] Big cities like New York City are lacking in treatment services and health offices as well as small rural areas . [ 39 ]
Between 1997 and 2003, the number of deaths related to opioid use increased eightfold, a figure that was echoed across other regions where OxyContin had a stronghold, primarily in Appalachian states.
There were around 68,700 drug overdose deaths in the United States in 2018. That is a rate of 210 deaths per million residents. [4] [5] Compare that rate to the 2018 rates of the European countries in the first chart below. Drug overdose death rates for European countries. [15] [16] Location links below are "Healthcare in LOCATION" links.
Oxycodone, marketed under the brand name Oxycontin, played a significant role in fueling the opioid epidemic in the United States. [19] Purdue Pharma ’s aggressive marketing tactics, including physician targeting and misleading advertising, contributed to the widespread overuse and overprescription of the drug. [ 20 ]
For the first time, an advertising company that worked on Purdue Pharma’s OxyContin account has settled a lawsuit that accused it of falsely marketing opioids as safe.. Publicis, a French ...
The article links Raymond and Arthur Sackler's business practices with the rise of direct pharmaceutical marketing and eventually to the rise of addiction to oxycodone in the United States. The article implies that the Sackler family bears some responsibility for the opioid epidemic in the United States. [130]